Lady Lovely
by on June 1, 2017
105 views
PUBLISHED: APR 12, 2017, 7:52 AM • UPDATED: 2 MONTHS AGO
By Alicia Wallace, The Cannabist Staff

The long play for Las Vegas-based GB Sciences involves developing and patenting a slew of pharmaceutical-grade cannabinoid therapies.

The short play starts with cannabis-infused coffee in a Keurig-compatible pod.

GB Sciences Inc., formerly operating as GrowBlox Sciences, inked a deal with Kush Cups to produce and distribute a line of cannabis-infused coffees and teas in single-use pods for Keurig-style coffee machines, company officials announced this week.

Cannabis in your cup
Homemade caramel coffee recipe: Pre-packaged cannabis coffee drinks are great, but this is better
Step aside, old school latte. Cannabis coffee is so 2017
Throw some beans into the pot: Weed-coffee makers hook caffeine fans
Highlights: Strange and wonderful Colorado happenings Oct. 16-22
Portland, Oregon — where $10 buys you a weed-infused coffee on Sunday
Financial terms were not disclosed for the agreement, which covers the production, distribution and sale of Kush Cups’ hot coffee, cold brew and teas within Nevada.

With the new partnership, the companies join a growing line of cannabis firms that have produced marijuana-infused coffee pods.

“I feel beyond strong. Words can’t explain,” Rick Chavez, founder of Kush Cups Nevada LLC, told The Cannabist. “A lot of people have this perception that a lot of categories in this industry are full. … There’s just endless possibilities.”

For Kush Cups, the company aimed to differentiate itself from the crowd by launching strain-specific coffee and tea products made via a cold-water hash-infused process, Chavez said. Until now, the products have been sold mostly in California with some presence in Arizona and Colorado, but the sourcing, testing and distribution aspects have been somewhat disjointed.

“This is allowing us to enter the Nevada market and perform a seamless operation from production all the way to (distribution),” he said.

And for GB Sciences, it’s the first deal of its kind for the firm and, as such, represents a key step toward building the company’s brand and meeting long-term goals, CEO John Poss said in an interview with The Cannabist.

“We’re not expecting this Kush deal to make or break us,” he said. “It’s the first in a series of deals we expect to announce where we will be signing up brands for Nevada and other states.”

While GB Sciences will make some plays in the infused products arena — Poss recently got a call from an energy drinks maker, for example — the heart of the operation remains entrenched in the science.

GB Sciences’ focus there includes cultivation, production, delivery technologies and drug discovery.
2 Liked
2 people like this.